Moderna, Inc. Common Stock
Symbol: MRNA (NASDAQ)
24.33
▼ (-0.57%) -0.140
Company Description:
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Key Stats
- Today's Open: $24.58
- Today's High: $25.319
- Today's Low: $24.215
- Today's Volume: 8.22M
- Yesterday Close: $24.47
- Yesterday High: $25.465
- Yesterday Low: $24.32
- Yesterday Volume: 9.78M
- Last Min Volume: 20
- Last Min High: $24.334
- Last Min Low: $24.33
- Last Min VWAP: $24.33
Company Profile
- Name: Moderna, Inc. Common Stock
- Website: https://www.modernatx.com
- Listed Date: 2018-12-07
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001682852
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $9.66B
- Round Lot: 100
- Outstanding Shares: 389.08M
- Asset Type: CS
RECENT FILINGS FOR MRNA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 4 | View |
| 2025-09-02 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-29 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-01 | 10-Q | View |
| 2025-08-01 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 144 | View |
| 2025-06-09 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-12 | SCHEDULE 13G | View |
| 2025-05-05 | 8-K | View |
| 2025-05-01 | 4 | View |
Latest News on MRNA